Negotiation & Access Agreements

Contracting value into access commitments

Building tender approaches, managed entry agreements and negotiation frameworks that translate clinical and economic value into contractual commitments, protecting access and revenue across regional markets.

Structuring negotiation as a market access function

By uniting economic modelling, stakeholder insight, and local data analytics, we operationalise negotiation into a measurable, market-ready capability across Middle Eastern and African markets.

Strategic levers for
contractual access

Tender & managed entry agreement strategy

We design tender and managed entry agreement strategy with pricing, volume and outcome clauses to align risk and commercial objectives regionally.

Negotiations & value communication training

We train teams to excel at payer negotiations and value communication translating clinical benefit into payer-acceptable commercial practices.

Patient support programme development

We develop patient support programmes that support adherence, reimbursement navigation and outcomes tracking to bolster access and demonstrate real-world value.

Explore our
Value & Access Suite

Strategic Market Assessment & Planning

We conduct comprehensive landscape analyses to help you identify market opportunities, inform early access strategies and guide launch sequencing.

Product Value & Pricing Strategy

We develop and test Target Product Profiles (TPP), assess willingness-to-pay and craft compelling value propositions to support your market positioning.

Evidence & HTA Support

We design integrated evidence plans and provide HTA submission support to demonstrate your product value to payers.

Policy, Advocacy & Stakeholder Engagement

We develop position papers, engage with key stakeholders and support policy to build the ecosystem that will drive your success.

Insights designed for
execution

Know More

Navigating the UAE’s Regulatory Shift: From Ambition to

The Future of Biopharma: China and Saudi Arabia are redefining “Pharmerging”

Strategic Defense against Generic Entry for Rare Disease Products in KSA

Let's talk

Whether you're expanding into the region or rethinking your local strategy, we're here to help.